Identification of N-alkylglycine trimers for induction of apoptosis

Details for Australian Patent Application No. 2004230207 (hide)

Owner Merck Patent GmbH

Inventors Tarrason, Gema; Piulats, Jaume; Cortes, Nuria; Cases, Claudia; Messeguer, Angel; Masip, Isabel

Agent Davies Collison Cave

Pub. Number AU-A-2004230207

PCT Pub. Number WO2004/092204

Priority 03008604.5 15.04.03 EP

Filing date 8 April 2004

Wipo publication date 28 October 2004

International Classifications

C07K 005/083 Peptides having up to four amino acids in a fully defined sequence

A61P 035/00 Antineoplastic agents

A61K 038/06 Medicinal preparations containing peptides - Tripeptides

A61K 031/337 - having four-membered rings, e.g. taxol

A61K 031/337 - having four-membered rings, e.g. taxol

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/092204 Priority application(s): WO2004/092204

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004230209-Quinazoline compounds useful as p38 kinase inhibitors

2004230206-Tubular mould for continuous casting